ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,489,000 | +141.7% | 14,967 | +164.9% | 0.10% | +134.1% |
| Q2 2019 | $616,000 | -75.7% | 5,649 | -78.5% | 0.04% | -66.2% |
| Q4 2018 | $2,532,000 | +85.5% | 26,257 | +134.5% | 0.13% | +261.1% |
| Q3 2018 | $1,365,000 | -83.7% | 11,197 | -85.3% | 0.04% | -83.4% |
| Q2 2018 | $8,370,000 | +554.9% | 76,212 | +536.4% | 0.22% | +442.5% |
| Q1 2018 | $1,278,000 | -88.6% | 11,975 | -88.6% | 0.04% | -86.8% |
| Q4 2017 | $11,187,000 | -59.6% | 104,779 | +26.2% | 0.30% | -73.0% |
| Q3 2017 | $27,696,000 | +305.5% | 83,025 | +276.9% | 1.13% | +326.5% |
| Q2 2017 | $6,830,000 | -16.8% | 22,026 | -28.8% | 0.26% | -41.3% |
| Q4 2016 | $8,209,000 | +61.2% | 30,933 | +56.3% | 0.45% | +113.3% |
| Q2 2016 | $5,094,000 | +551.4% | 19,796 | +559.9% | 0.21% | +339.6% |
| Q1 2016 | $782,000 | -87.6% | 3,000 | -85.6% | 0.05% | -76.9% |
| Q3 2015 | $6,305,000 | +107.8% | 20,786 | +107.9% | 0.21% | +116.7% |
| Q4 2014 | $3,034,000 | – | 10,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |